Exchange: NYSEMkt·Updated 04:00 AM EDT
MAIA logo

MAIA MAIA Biotechnology Inc

$1.31
$0.00
(0.00%)
Pre-Market
Prev Close $1.31
Reported EarningsAug 5
Mkt Cap$80.9M
Vol20.00

About MAIA

MAIA Biotechnology, Inc. is a clinical stage biotechnology company that is engaged in the discovery, development and commercialization of therapies targeting cancer. Its product, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company was founded on August 3, 2018 and is headquartered in Chicago, IL.
53

Neutral Sentiment

How do you feel about MAIA?

Advertisement|Remove ads.